The effects of exosomes and related vesicles on cancer development, progression, and dissemination

Emerging Concepts of Tumor Exosome-Mediated Cell-Cell Communication

Volumn , Issue , 2014, Pages 107-129

  Zhang, Huang Ge ^a   Grizzle, William E ^b  

^a University of Louisville School of Medicine   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Autocrine; Endocrine; Exosomes; Intercellular communication; Nanoparticles; Paracrine

Indexed keywords

EID: 84884367344     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3697-3_5     Document Type: Chapter

References (116)

1. Trams EG, Lauter CJ, Salem N Jr, Heine U (1981) Exfoliation of membrane ecto-enzymes in the form of microvesicles. Biochim Biophys Acta 645:63-70
2. Johnstone RM, Adam JR, Hammond LO, Turbide C (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262:9412-9420
3. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C., et al. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297-303
4. Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA et al (2001) Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods 247:163-174
5. Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569-579
6. Denzer K, Kleijmeer MJ, Heijnen HFG, Stoorvogel W, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113:3365-3374
7. Van Dijk EL, Schilders G, Pruijn JM (2007) Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways. RNA 13:1027-1035
8. Zhang H-G, Grizzle WE (2011) Exosomes and cancer: a newly described pathway of immune suppression. Clin Cancer Res 17(5):1-6
9. Zhang H-G, Liu Y, Deng Z-B, Liu C, Xiang X, Grizzle WE (2012) Exosomes and immune surveillance of neoplastic lesions: a review. Biotech Histochem 87(3):161-168
10. Théry C, Duban L, Seguar E, Véron P, Lantz O, Amigorena S (2002) Indirect activation of naïve CD4+T cells by dendritic cell-derived exosomes. Nat Immunol 3(12):1156-1162
11. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, Pain S, Raposo G, Benaroch P et al (2002) Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol 14:713-722
12. Andre F, Chaput N, Schartz NEC Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu D-H, Tursz T, Amigorena S, Angevin E, Zitvogel L (2004) Exosomes are potent cell-free peptide-based vaccine. I. dendritic cell-derived exosomes tranfer functional MHC class 1/peptide complexes to dendritic cells. Blood 172:2126-2136
13. Chaput N, Schartz NEC, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G, Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin E, Zitvogel L (2004) Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naïve Tc1 lymphocytes leading to tumor rejection. J Immunol 172:2137-2146
14. Qazo KR, Gehrmann U, Jordö ED, Karlsson MCI, Gabrielsson S (2009) Antigen-loaded exosomes alone induce Th 1-type memory thruogh a B cell-dependent mechanism. Blood 113:2673-2683
15. Hedlund M, Stenqvist A-C, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L (2009) Human placenta expresses and secretes NKG2D ligands via exosomes that downmodulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol 183(1):340-351
16. Mincheva-Nilsson L (2006) Immune cells and molecules in pregnancy: friends or foes to the fetus? Exp Rev Clin Immunol 2:457-470
17. Sabapatha A, Gerçel-Taylor C, Taylor DD (2006) Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol 56:345-355
18. Taylor DD, Akyol S, Gerçel-Taylor C (2006) Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol 176:1534-1542
19. Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL (2005) Fas ligandpositive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Cancer Res 11:1010-1020
20. Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, Robbins PD (2006) Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol Therapy 13(2):289-300
21. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL et al (2005) Tumor exosomes expressing Fas ligand mediate CD8+T-cell apoptosis. Blood Cells Mol Dis 35:169-173
22. Wang GJ, Liu Y, Qin A, Shah SV, Deng ZB, Xiang X, Cheng Z, Liu C, Wang J, Zhang L, Grizzle WE, Zhang HG (2008) Thymus exosomes-like particles induce regulatory T cells. J Immunol 181:5242-5248
23. Kim SH, Lechman ER, Bianco N, Menon R, Keravala A, Nash J et al (2004) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 174:6440-6448
24. Zhang HG, Liu C, Su K, Yu S, Zhang L, Zhang S, Wang J, Cao X, Grizzle W, Kimberly RP (2006) A membrane form of TNF-alpha presented by exosomes delays T cell activationinduced cell death. J Immunol 176:7385-7393
25. Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2005) Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 52:1517-1521
26. Deng ZB, Liu Y, Liu C, Xiang X, Wang J, Cheng Z, Shah SV, Zhang S, Zhang L, Zhuang X, Michalek S, Grizzle WE, Zhang HG (2009) Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 50(5):1412-1420 (PMCID: PMC2852608)
27. Grizzle WE, Srivastava S, Manne U (2012) Translational Pathology of Cancer. In: S Srivastava, WE Grizzle (eds) Translational pathology of early cancer. IOS Press, Amsterdam (in press)
28. Grizzle WE, Srivastava S, Manne U (2012) The biology of incipient, pre-invasive or intraepithelial neoplasia. In: S Srivastava, WE Grizzle (eds) Translational pathology of early cancer. IOS Press, Amsterdam (in press)
29. Grizzle WE, Srivastava S, Manne U (2012) The genetics of early cancer. In: S Srivastava, WE Grizzle (eds) Translational pathology of early cancer. IOS BV, Amsterdam (in press)
30. Graner MW, Cumming RI, Bigner DD (2007) The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequences. J Neurosci 27:11214-11227
31. Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, Sjöstrand M, Gabrielsson S, Lötvall J, Valadi H (2011) Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 9:9
32. Harrington MG, Fonteh AH, Oberins E, Lise P, Cowan RP, McComb G, Chavez JN, Rush J, Biringer RG, HühmerAF (2009) The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid. Cerebrospinal Fluid Res 6:10
33. Admyre C, Grunewald J, Thyberg S, Gripenbäck S, Tornling G, Eklund A, Scheynius A, Gabrielsson S (2003) Exosomes with major histocompatibility complex class II and co-stimulatory molecles are present in human BAL fluid. Eur Respir J 22:578-583
34. Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong DT (2010) Nanostructural and transcriptomic analyses of human salive derived exosomes. PLoS ONE 5(1):38577. doi:10.1371/journalo.pone.008577
35. Skriner K, Adolph K, Jungblut PR, Burmester GR (2006) Association of citrullinated proteins with synovial exosomes. Arthritis Rheum 54:3809-3814
36. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C et al (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297-303
37. Logozzi M, de Milito A, Lugini L, Borghi M, Calabrò L, Spada M, Perdicchio M, Marino ML, Federici C, Lessi E, Brambilla D, Venturi G, Lozopone F, Santinami M, Huber V, Maio M, Rivoltini L, Fais S (2009) High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4(4):e5219. doi:10.1371/journal.pone.0005219
38. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, Bigner DD (2009) Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 23:1541-1557
39. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, SenaShahikantEsteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470-1476
40. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J (2009) Endothelial expression of autocrineVEGFupon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 106 (10) L: 3794-3799
41. AL-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10(5):619-624
42. Hood JL, Pan H, Lanza GM, Wickline SA (2009) Consortium for translational research in advanced imaging and nanomedicine (C-TRAIN). Paracrine induction of endothelium by tumor exosomes. Lab Invest 89:1317-1328
43. Castellana D, Zobairi F, Martinez MC, Panaro MA, Mitolo V, Freyssinet JM, Kunzelmann C (2009) Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 69(3):785-793
44. Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK (2010) Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 9:1085-1099
45. Hong BS, Cho J-H, Kim H, Choi E-J, Rho S, Kim J, Kim JH, Choi D-S, Kim Y-K, Hwang D, Ghoo YS (2009) Colorectal cancer cell-derived microvesicles are enriched in cell cyclerelated mRNAs that promote proliferation of endothelial cells. BMC Genomics 10:556. doi:10.1186/1471-2164-10-556
46. Gesierich S, Berezovskly I, Ryschich E, Zöller M (2006) Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res 66:7083-7094
47. Antonyak MA, Li B, Boroughs LK, Johnson JL, Druso JE, Bryant KL, Holowks DA, Cerione RA (2011) Cancer cell-derived microvesicles induce transformation by tranferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci U S A 12:4852-4857
48. Ristorcelli E, Beraud E, Verrando P, Villard C, Lafitte D, Sbarra V, Lombardo D, Verine A (2008) Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J 22(9):3358-3369
49. Ristorcelli E, Beraud E, Mathieu S, Lombardo D, Verine A (2009) Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int J Cancer 125(5):1016-1026
50. Koga K, Matsumoto K, Akuyoshi T, Kubo M, Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M, Katano M (2005) Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 25(6 A):3703-3707
51. Meckes DG Jr, Shair KHY, Marquitz AR, Kung C-P, Edwards RH, Raab-Traub N (2010) Human tumor virus utilizes exosomes for intercellular communication. PNAS 107(47):20370-20375
52. Qu JL, Qu XJ, Zhao MF, GTeng JE, Zhang Y, Hou KZ, Jiang YH, Yang XH, Liu YP (2009) Gastric cancer exosomes promote tumour cell proliferation through P13K/Akt and MAPK/ERK activation. Dig Liver Dis 41(12):875-880
53. Khan S, Jutzy JMS, Aspe JR, McGregor DW, Neidigh JW, Wall NR (2011) Survivin is released from cancer cells via exosomes. Apoptosis 16:1-12
54. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (2010) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70(23):9621-9630
55. Jung T, Castellana D, Klingbell P, Hernández IC, Vitacolonna M, Orlicky DJ, Roffler SR, Brodt P, Zöller M (2009) CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 11(10):1093-1105
56. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, de Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S (2009) Microenvironment pH is a key factor for exosomes traffic in tumor cells. J Biol Chem 284(49):34211-34222
57. Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z (2005) Induction of heat shock proteins in B-cell exosomes. J Cell Sci 118:3631-3638
58. McNally LR, Welch DR, Beck BH, Stafford LJ, Long JW, Sellers JC, Huang ZQ, Grizzle WE, Stockard CR, Nash KT, Buchsbaum DJ (2010) KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis 27(8):591-600
59. Hood JL, San RS, Wickline SA (2011) Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71:3792. doi:10.1158/0008-5472. CAN-10-4455
60. Zhang HG, Grizzle WE (2003) Aging, immunity, and tumor susceptibility. Immunol Allergy Clin North Am 23:83-102
61. Liu C, Yu S, Zinn K, Wang J, Zhang L, Yujiang J, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang H-G (2006) Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 176:1375-1385
62. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S et al (2008) Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 15:80-88
63. Taylor DD, Gercel-Taylor C, Lyons KS, Stanson J, Whiteside TL (2003) T-cell apoptosis and suppression of T-cell receptor/CD3-ζ by fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res 9:5113-5119
64. Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Zsuzsanna T (2008) Human tumorderived exosomes down-modulate NKG2D expression. J Immunol 180:7249-7258
65. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D et al (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4:594-600
66. Andre F, Shartz NE, Movassagh M, Flament C, Pautier P, Morice P et al (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360:295-305
67. Andre F, Escudier B, Angevin E, Tursz T, Zitvogel L (2004) Exosomes for cancer immunotherapy. Ann Oncol 15:141-144
68. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L (2006) Human tumor-released microvesicles promote the differentiation of myloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes. Cancer Res 66:9290-9298
69. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L (2007) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67:2912-2915
70. Yu S, Liu C, Su K, Wang J, Liu Y, Zhang L et al (2007) Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 178:6867-6875
71. Luketic L, Delanghe J, Sobol PT, Yang P, Frotten E, Mossman KL et al (2007) Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J Immunol 179:5024-5032
72. Viaud S, Terme M, Flament C, Taieb J, Andre F, Novault S et al (2009) Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS ONE 4:e4942
73. Van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R (2009) Cell-derived microvesicles and cancer. J Med 67(7):266-273
74. Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, Wang J et al (2009) Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer 124:2621-2633
75. Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR et al (2007) Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109:4336-4342
76. Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Sem Cancer Biol 16:53-65
77. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162-174
78. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC (2007) Arginase, prostaglandins and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13:721-736
79. Diaz-Montero CM, Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 58:49-59
80. Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin J-P, Boireau W, Rouleau A, Simon B, Lanneau D, De Thonel A, Multhoff G, Hamman A, Martin F, Chauffert B, Solary E, Zitvogel L, Garrido C, Ryffel B, Borg C, Apetoh L, Rébé C, Ghiringhelli F (2010) Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 120:457-471
81. Liu Y, Xiang X, Zhang X, Zhang S, Liu C, Cheng Z, Michalek SM, Grizzle WE, Zhang HG (2010) Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am J Pathol 176:2490-2499
82. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL (2010) Tumorderived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS ONE 5:e1149. doi:10.1371/journal.pone.0011469
83. Xiang X, Liu Y, Zhuang X, Zhang S, Michalek S, Taylor DD, Grizzle W, Zhang H-G (2010) TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes. Am J Pathol 177(4):1606-1610
84. Blanc L, Barres C, Bette-Bobillo P, Vidal M (2007) Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase. Blood 110:3407-3416
85. Blanc L, De Gassart A, Geminard C, Bette-Bobillo P, Vidal M (2005) Exosome release by reticulocytes-an integral part of the red blood cell differentiation system. Blood Cells Mol Dis 35:21-26
86. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63:4331-4337
87. Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W, Howell SB (2005) Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 4:1595-1604
88. Chen YY, Posada MM, Blazer LL, Zhao T, Rosania GR (2006) The role of the VPS4Aexosome pathway in the intrinsic egress route of a DNA-binding anticancer drug. Pharm Res 23(8):1687-1695
89. Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin P (2009) Claudincontaining exosomes in the peripheral circulation ofwomen with ovarian cancer. BMCCancer 9:244
90. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10:42-46
91. Mallick R, Patnaik SK, Yendamuri S (2010) MicroRNAs and lung cancer: biology and applications in diagnosis and prognosis. J Carcinog 9:8
92. Lu Q, Zhang J, Allison R, Gay H, Yang W-X, Bhowmick NA, Frelix G, Shappell S, Chen Y-H (2009) Identification of extracellular δ-Catenin accumulation for prostate cancer detection. Prostate 69:411-418
93. Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, Widmark A (2009) Prostate cancer-derived urine exosomes: a novdel approach to biomarkers for prostate cancer. Br J Cancer 100:1603-1607
94. Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, Clayton A (2009) Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med 7:4
95. Jansen FH, Krijgsveld J, van Rijswijk A, van den Bernd G-J, van den Berg MS, van Weerden WM, Willemsen R, Dekker LJ, Luider TM, Jenster G (2009) Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins. Mol Cell Proteomics 8:1192-1205
96. Klein-Scory S, Kübler S, Diehl H, Eilert-Micus C, Reinacher-Schick A, Stuhler K, Warscheid B, Meyer HE, Schmiegel W, Schwarte-Waldhoff I (2010) Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer 10:70. doi:10.1186/1471-2407-10-70
97. Morrissey JJ, London AN, Luo J, Kharasch ED (2010) Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc 85(5):413-421
98. Grebe SK, Erickson LA (2010) Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin? Mayo Clin Proc 85(5):410-412
99. Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A (2010) Proteomics analysis of bladder cancer. Mol Cell Proteomics 9:1324-1338
100. Poliakov A, Spilman M, Dokland T, Amling CL, Mobley JA (2009) Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 69:159-167
101. Taylor DD, Gerçel-Taylor C (2005) Tumour-derived exosomes and their role in cancerassociated T-cell signalling defects. Br J Cancer 92:305-311
102. Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Miney BR, Min WP, Tullis RH (2008) Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med 6:37
103. Iessi E, Marino ML, Lozupone F, Fais S, de Milito A (2008) Tumor acidity and malignancy: novel aspects in the design of anti-tumor therapy. Cancer Therapy 6:55-66
104. Zhang HG, Kim H, Liu C, Yu S, Wang J, Grizzle WE et al (2007) Curcumin reverses breast tumor exosomes mediated immune suppression of NKcell tumor cytotoxicity. Biochim Biophys Acta 1773:1116-1123
105. Narayanan NK, Nargi D, Randolph C, Narayanan BA (2009) Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125:1-8
106. Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Grizzle W, Miller D, Zhang H-G (2010) A novel nanoparticle drug delivery system. The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Therapy (in press)
107. Mishra PR, Jain NK (2003) Folate conjugated Doxorubicin-loaded membrane vesicles for improved cancer therapy. Drug Deliv 10(4):277-282
108. Chen TS, Arsian F, Yin Y, Tan SS, Lai RC, Choo ABH, Padmanabhan J, Lee CN, de Kleijn DPV, Lim SK (2011) Enabling a robust scalable manufacturing process for therapeutic exosomes through ocogenic immortalization of human ESC-derived MSCs. J Transl Med 9:47
109. Camussi G, Deregibus M-C, Brunpo S, Grange C, Fonsato V, Tetta C (2011) Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 1(1):98-110
110. Deng Z, Cheng Z, Xiang X, Yan J, Zhuang X, Lkiu C, Jiang H, Ju S, Zhang L, Grizzle W, Mobley J, Roman J, Miller D, Zhang HG (2012) Tumor cell cross talk with tumor-associated leukocytes leads to induction of tumor exosomal fibronectin and promotes tumor progression. Am J Pathol 180(1):390-398
111. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S (2001) Proteomic analysis of dendritic cell-drived exosomes: a secreted subcellular compartment distinct form apoptotic vesicles. J Immunol 166:7309-7318
112. Van Niel G, Mallegol J, Bevilacqua C, Candalh C, Brugière S, Tomaskovic-Crook E, Heath JK, Cerf-Besussan N, Heyman M (2003) Investinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. GUT 52:1690-1697
113. Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M, Lochnit G, Preissner KL, Zöller M (2010) Cell surface tetraspanin tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 70:1668. doi:10.1158/0008-5472. CAN-09-2470
114. Morelli AE, Larregina AT, Shufesky WJ, Sullivan MMLG, Sullivan DBS, Papworth GD, Zahorchak AF, Logar AJ, Wang Z, Watkins SC, Falo, LD Jr, Thomson AW (2004) Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104:3257-3266
115. Caby M-P, Lankar D, Vincendeau-Scherrer Raposo G, Bonnerot C (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17(7):879-887
116. Koumangoye RB, Sakwe AM, Goodwin JS, Patel T, Ochieng J (2011) Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS ONE 6(9):e24234. doi:10.1371/journal.pone.0024234